ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,904, issued on Sept. 23, was assigned to DILAFOR AB (Solna, Sweden).
"Medical use of tafoxiparin" was invented by Lena Degling-Wikingsson (Spanga, Sweden) and Gunvor Ekman-Ordeberg (Danderyd, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to tafoxiparin for use in the spontaneous onset of labor in a term pregnant woman, wherein tafoxiparin is administered in a daily dose of 30-320 mg per day."
The patent was filed on Feb. 4, 2025, under Application No. 19/045,102.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p...